Thursday, June 14, 2012

The E-Clinical Technologies Summit Brochure is Ready for Download

The 16th Annual E-Clinical Technologies Summit is part of this year's 2nd Annual Clinical Business Expo (CBE), Sept. 18-20 in Boston, MA.  We hope it will be your new action plan to control costs and increase quality in clinical trials.

In an innovation-driven pharmaceutical environment, regulatory pressures and uncertainly continue to antagonize the process of drug development. Recently, there has been a shift from data collection and subsequent warehousing to a strategy-driven focus on the value of data. With regulatory uncertainties still looming, today’s e-Clinical Technology professional must process the increasing volume and detail of information captured by the rise of multimedia.

Your top E-Clinical concerns are constantly plagued by unanswered regulatory queries:
  • • What is the future direction of the FDA when it comes to data standards?
  • • How can you optimize the electronic submission process?
  • • How are FDA official adjusting their processes to keep up with modernization?
Hear the answers to all of these regulatory concerns and MORE directly from the source – CBE Keynote speaker, Dr. Eric Perakslis, Chief Information Officer and Chief Scientist (Informatics) at the FDA.

Plus this event is part of the Clinical Business Expo!  With five of the leading clinical operations events under one roof, the Clinical Business Expo gives you everything you need to stay on top of new directions in drug development while you collaborate with CROs and niche service providers specializing in lab, data, sample and clinical supply chain management that would other-wise be difficult and time-consuming to meet in person.

E-Clinical Technologies Summit and the Clinical Business Expo will take place September 19-20, 2012 with a pre-conference day September 18. As a reader of this blog, when you register to join us today and mention code XP1725BLOG, you’ll save 15% off the standard rate! If you have any questions, feel free to email Jennifer Pereira.

No comments: